Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M64,661Revenue (TTM) $M11,416Net Margin (%)34.0Altman Z-Score6.6
Enterprise Value $M66,877EPS (TTM) $17.7Operating Margin %47.6Piotroski F-Score5
P/E(ttm)16.8Beneish M-Score-2.3Pre-tax Margin (%)45.4Higher ROA y-yN
Price/Book5.310-y EBITDA Growth Rate %26.0Quick Ratio2.8Cash flow > EarningsY
Price/Sales5.85-y EBITDA Growth Rate %30.6Current Ratio3.2Lower Leverage y-yY
Price/Free Cash Flow20.3y-y EBITDA Growth Rate %18.3ROA % (ttm)18.6Higher Current Ratio y-yN
Dividend Yield %--PEG0.6ROE % (ttm)36.1Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M218ROIC % (ttm)31.0Gross Margin Increase y-yN

Gurus Latest Trades with BIIB

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
BIIBJohn Paulson 2016-09-30 Add0.64%$242.03 - $330.11
($296.18)
$ 297.190%Add 150.20%308,000
BIIBJoel Greenblatt 2016-09-30 Reduce-0.36%$242.03 - $330.11
($296.18)
$ 297.190%Reduce -33.31%245,468
BIIBFirst Eagle Investment 2016-09-30 Add0.1%$242.03 - $330.11
($296.18)
$ 297.190%Add 37.41%457,260
BIIBHOTCHKIS & WILEY 2016-09-30 Add0.1%$242.03 - $330.11
($296.18)
$ 297.190%Add 33.67%306,100
BIIBVanguard Health Care Fund 2016-09-30 Reduce-0.1%$242.03 - $330.11
($296.18)
$ 297.190%Reduce -4.98%3,759,703
BIIBGeorge Soros 2016-09-30 Buy 0.02%$242.03 - $330.11
($296.18)
$ 297.190%New holding1,994
BIIBRonald Muhlenkamp 2016-09-30 Reduce-0.02%$242.03 - $330.11
($296.18)
$ 297.190%Reduce -0.95%23,478
BIIBRon Baron 2016-09-30 Reduce-0.02%$242.03 - $330.11
($296.18)
$ 297.190%Reduce -66.48%6,577
BIIBMario Gabelli 2016-09-30 Reduce-0.01%$242.03 - $330.11
($296.18)
$ 297.190%Reduce -60.45%1,897
BIIBRichard Pzena 2016-09-30 Buy $242.03 - $330.11
($296.18)
$ 297.190%New holding642
BIIBKen Fisher 2016-09-30 Reduce$242.03 - $330.11
($296.18)
$ 297.190%Reduce -1.18%100,718
BIIBHOTCHKIS & WILEY 2016-06-30 Buy 0.24%$224.6 - $290.23
($263.49)
$ 297.1913%New holding229,000
BIIBJoel Greenblatt 2016-06-30 Add0.2%$224.6 - $290.23
($263.49)
$ 297.1913%Add 23.24%368,095
BIIBVanguard Health Care Fund 2016-06-30 Add0.08%$224.6 - $290.23
($263.49)
$ 297.1913%Add 3.85%3,956,663
BIIBFirst Eagle Investment 2016-06-30 Add0.07%$224.6 - $290.23
($263.49)
$ 297.1913%Add 48.17%332,760
BIIBRonald Muhlenkamp 2016-06-30 Reduce-0.02%$224.6 - $290.23
($263.49)
$ 297.1913%Reduce -0.63%23,703
BIIBDavid Dreman 2016-06-30 Buy 0.02%$224.6 - $290.23
($263.49)
$ 297.1913%New holding150
BIIBKen Fisher 2016-06-30 Add0.01%$224.6 - $290.23
($263.49)
$ 297.1913%Add 12.74%101,919
BIIBJohn Paulson 2016-06-30 Add0.01%$224.6 - $290.23
($263.49)
$ 297.1913%Add 3.97%123,100
BIIBRon Baron 2016-06-30 Add0.01%$224.6 - $290.23
($263.49)
$ 297.1913%Add 22.27%19,621
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

BIIB is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


BIIB: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Karaboutis AdrianaEVP, Tech, Bus. Sol & Corp Aff 2016-10-04Sell262$311.94-4.73view
Karaboutis AdrianaEVP, Tech, Bus. Sol & Corp Aff 2016-10-03Sell380$313-5.05view
DORSA CAROLINEDirector 2016-09-22Sell27,570$314-5.35view
SCANGOS GEORGE ACEO 2016-07-21Sell157$2806.14view
Koppel AdamEVP, Strategy and Bus. Dev. 2016-06-06Sell555$2902.48view
SCANGOS GEORGE ACEO 2016-06-03Sell842$2902.48view
SCANGOS GEORGE ACEO 2016-06-01Sell3,855$289.742.57view
SCANGOS GEORGE ACEO 2016-05-25Sell157$2806.14view
SCANGOS GEORGE ACEO 2016-05-02Sell487$274.748.17view
Koppel AdamEVP, Strategy and Bus. Dev. 2016-04-06Sell102$2758.07view

Press Releases about BIIB :

Quarterly/Annual Reports about BIIB:

News about BIIB:

Articles On GuruFocus.com
John Paulson's Largest 3rd Quarter Trades Dec 01 2016 
Gurus Invest in Undervalued Biotech Stocks Nov 25 2016 
Paul Tudor Jones Exits EMC, Boosts Facebook, PepsiCo, Biogen Nov 23 2016 
Jeff Auxier Expands Holdings in Chemical and Biotech Companies Nov 21 2016 
Vanguard Health Care Fund Sells Amgen, Baxter Nov 02 2016 
First Eagle Fund of America 3rd Quarter Commentary Oct 28 2016 
Eaton Vance Worldwide Health Sciences Fund 3rd Quarter Commentary Oct 26 2016 
Spiros Segalas Sells Alphabet, Netflix and Apple Oct 05 2016 
Sarah Ketterer Takes 3 Positions in 2nd Quarter Aug 15 2016 
Richard Snow Slashed Abercrombie & Fitch Stake in 2nd Quarter Aug 12 2016 

More From Other Websites
Biogen Spinoff Gets Gene Therapy Drugs (BIIB, SGMO) Dec 02 2016
Biogen MS Drug Sued for Patent Infringement (BIIB) Dec 02 2016
Biogen may have edge in high-stakes Tecfidera patent battle, analyst says Dec 02 2016
[$$] Patent Feud Is Underappreciated Risk at Biogen Dec 02 2016
INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Biogen Inc. and... Dec 01 2016
[$$] Patent Feud Is Underappreciated Risk at Biogen Dec 01 2016
ETFs with exposure to Biogen, Inc. : December 1, 2016 Dec 01 2016
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against... Dec 01 2016
Biogen, Forward Square Off In Multiple Sclerosis Patent Battle Nov 30 2016
INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Biogen Inc. and... Nov 30 2016
BIIB INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Shareholders of a Class Action... Nov 30 2016
After Lilly Bombs, Could Alzheimer's Become Healthcare's Trumpshot? Nov 30 2016
Biotech Stock Mailbag: Looking for an Investable Idea in Alzheimer's Minefield Nov 30 2016
Biogen, Inc. breached its 50 day moving average in a Bearish Manner : BIIB-US : November 30, 2016 Nov 30 2016
Visualizing Financial Trends With Interactive Charts, Other Topics Nov 29 2016
Biogen loses $4 billion in market cap on Eli Lilly Alzheimer's news Nov 29 2016
IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against... Nov 28 2016
[$$] Biogen Unfazed by Lilly Disappointment Nov 28 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)